Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Case studies of the spatial heterogeneity of DNA viruses in the cystic fibrosis lung.

Willner D, Haynes MR, Furlan M, Hanson N, Kirby B, Lim YW, Rainey PB, Schmieder R, Youle M, Conrad D, Rohwer F.

Am J Respir Cell Mol Biol. 2012 Feb;46(2):127-31. doi: 10.1165/rcmb.2011-0253OC. Epub 2011 Oct 6.

2.

Metagenomic analysis of respiratory tract DNA viral communities in cystic fibrosis and non-cystic fibrosis individuals.

Willner D, Furlan M, Haynes M, Schmieder R, Angly FE, Silva J, Tammadoni S, Nosrat B, Conrad D, Rohwer F.

PLoS One. 2009 Oct 9;4(10):e7370. doi: 10.1371/journal.pone.0007370.

3.

Deciphering the role of phage in the cystic fibrosis airway.

Willner D, Furlan M.

Virulence. 2010 Jul-Aug;1(4):309-13. doi: 10.4161/viru.1.4.12071.

PMID:
21178461
4.

The human skin double-stranded DNA virome: topographical and temporal diversity, genetic enrichment, and dynamic associations with the host microbiome.

Hannigan GD, Meisel JS, Tyldsley AS, Zheng Q, Hodkinson BP, SanMiguel AJ, Minot S, Bushman FD, Grice EA.

MBio. 2015 Oct 20;6(5):e01578-15. doi: 10.1128/mBio.01578-15.

5.

Metagenomics and metatranscriptomics: windows on CF-associated viral and microbial communities.

Lim YW, Schmieder R, Haynes M, Willner D, Furlan M, Youle M, Abbott K, Edwards R, Evangelista J, Conrad D, Rohwer F.

J Cyst Fibros. 2013 Mar;12(2):154-64. doi: 10.1016/j.jcf.2012.07.009. Epub 2012 Aug 28.

6.

Spatial distribution of microbial communities in the cystic fibrosis lung.

Willner D, Haynes MR, Furlan M, Schmieder R, Lim YW, Rainey PB, Rohwer F, Conrad D.

ISME J. 2012 Feb;6(2):471-4. doi: 10.1038/ismej.2011.104. Epub 2011 Jul 28.

7.

Bacteriophages as vehicles of the resistome in cystic fibrosis.

Rolain JM, Fancello L, Desnues C, Raoult D.

J Antimicrob Chemother. 2011 Nov;66(11):2444-7. doi: 10.1093/jac/dkr318. Epub 2011 Aug 4. Review.

PMID:
21816766
8.

Biogeochemical forces shape the composition and physiology of polymicrobial communities in the cystic fibrosis lung.

Quinn RA, Lim YW, Maughan H, Conrad D, Rohwer F, Whiteson KL.

MBio. 2014 Mar 18;5(2):e00956-13. doi: 10.1128/mBio.00956-13.

9.

Incidence of viral respiratory pathogens causing exacerbations in adult cystic fibrosis patients.

Hoek RA, Paats MS, Pas SD, Bakker M, Hoogsteden HC, Boucher CA, van der Eerden MM.

Scand J Infect Dis. 2013 Jan;45(1):65-9. doi: 10.3109/00365548.2012.708942. Epub 2012 Sep 19.

PMID:
22992129
10.

Viral respiratory infections in cystic fibrosis.

van Ewijk BE, van der Zalm MM, Wolfs TF, van der Ent CK.

J Cyst Fibros. 2005 Aug;4 Suppl 2:31-6. Review.

11.

Activated MCTC mast cells infiltrate diseased lung areas in cystic fibrosis and idiopathic pulmonary fibrosis.

Andersson CK, Andersson-Sjöland A, Mori M, Hallgren O, Pardo A, Eriksson L, Bjermer L, Löfdahl CG, Selman M, Westergren-Thorsson G, Erjefält JS.

Respir Res. 2011 Oct 20;12:139. doi: 10.1186/1465-9921-12-139.

12.

Pseudomonas aeruginosa biofilms in cystic fibrosis.

Høiby N, Ciofu O, Bjarnsholt T.

Future Microbiol. 2010 Nov;5(11):1663-74. doi: 10.2217/fmb.10.125. Review.

PMID:
21133688
13.

Regional Isolation Drives Bacterial Diversification within Cystic Fibrosis Lungs.

Jorth P, Staudinger BJ, Wu X, Hisert KB, Hayden H, Garudathri J, Harding CL, Radey MC, Rezayat A, Bautista G, Berrington WR, Goddard AF, Zheng C, Angermeyer A, Brittnacher MJ, Kitzman J, Shendure J, Fligner CL, Mittler J, Aitken ML, Manoil C, Bruce JE, Yahr TL, Singh PK.

Cell Host Microbe. 2015 Sep 9;18(3):307-19. doi: 10.1016/j.chom.2015.07.006. Epub 2015 Aug 20.

14.

The cystic fibrosis lower airways microbial metagenome.

Moran Losada P, Chouvarine P, Dorda M, Hedtfeld S, Mielke S, Schulz A, Wiehlmann L, Tümmler B.

ERJ Open Res. 2016 May 9;2(2). pii: 00096-2015. eCollection 2016 Apr.

15.

Metagenomic analysis of double-stranded DNA viruses in healthy adults.

Wylie KM, Mihindukulasuriya KA, Zhou Y, Sodergren E, Storch GA, Weinstock GM.

BMC Biol. 2014 Sep 10;12:71. doi: 10.1186/s12915-014-0071-7.

16.

Adaptation of Staphylococcus aureus to the cystic fibrosis lung.

Goerke C, Wolz C.

Int J Med Microbiol. 2010 Dec;300(8):520-5. doi: 10.1016/j.ijmm.2010.08.003. Epub 2010 Sep 16. Review.

PMID:
20843740
17.

Pulmonary Exacerbations in Children with Cystic Fibrosis.

Waters V, Ratjen F.

Ann Am Thorac Soc. 2015 Nov;12 Suppl 2:S200-6. doi: 10.1513/AnnalsATS.201502-098AW. Review.

PMID:
26595740
18.

A Different Microbiome Gene Repertoire in the Airways of Cystic Fibrosis Patients with Severe Lung Disease.

Bacci G, Mengoni A, Fiscarelli E, Segata N, Taccetti G, Dolce D, Paganin P, Morelli P, Tuccio V, De Alessandri A, Lucidi V, Bevivino A.

Int J Mol Sci. 2017 Jul 29;18(8). pii: E1654. doi: 10.3390/ijms18081654.

19.

Current concepts: host-pathogen interactions in cystic fibrosis airways disease.

Tang AC, Turvey SE, Alves MP, Regamey N, Tümmler B, Hartl D.

Eur Respir Rev. 2014 Sep;23(133):320-32. doi: 10.1183/09059180.00006113. Review.

20.

The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation.

Etherington C, Naseer R, Conway SP, Whitaker P, Denton M, Peckham DG.

J Cyst Fibros. 2014 Jan;13(1):49-55. doi: 10.1016/j.jcf.2013.06.004. Epub 2013 Jul 23.

Supplemental Content

Support Center